20/20 Biolabs (AIDX) SEC Filings: History & Chart

20/20 Biolabs Inc.(AIDX)

Medical - Care Facilities · Gaithersburg, MD

$0.35-0.03 (-7.26%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About 20/20 Biolabs Inc.

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Gaithersburg, MD

14 employees

2020biolabs.com

Healthcare / Medical - Care Facilities

Sector: Healthcare
Industry: Medical - Care Facilities
CEO: Jonathan Cohen

View full financials

Form	Filing Date	Accepted	Document
8-K	Sep 18, 2026	Sep 18, 2026	View filing
8-K	Sep 10, 2026	Sep 10, 2026	View filing
8-K	Sep 2, 2026	Sep 2, 2026	View filing
DEFA14A	Aug 19, 2026	Aug 19, 2026	View filing
8-K	Aug 19, 2026	Aug 19, 2026	View filing
424B3	Aug 17, 2026	Aug 17, 2026	View filing
424B3	Aug 17, 2026	Aug 17, 2026	View filing
8-K	Aug 17, 2026	Aug 17, 2026	View filing
10-Q	Aug 14, 2026	Aug 14, 2026	View filing
8-K	Aug 5, 2026	Aug 5, 2026	View filing
8-K	Jul 22, 2026	Jul 22, 2026	View filing
8-K	Jul 1, 2026	Jul 1, 2026	View filing
DEFA14A	Jun 23, 2026	Jun 23, 2026	View filing
DEF 14A	Jun 23, 2026	Jun 23, 2026	View filing
PRE 14A	Jun 1, 2026	Jun 1, 2026	View filing
8-K	May 26, 2026	May 26, 2026	View filing
424B3	May 21, 2026	May 21, 2026	View filing
424B3	May 21, 2026	May 21, 2026	View filing
10-Q	May 20, 2026	May 20, 2026	View filing
8-K	May 20, 2026	May 20, 2026	View filing
NT 10-Q	May 15, 2026	May 15, 2026	View filing
424B3	Apr 28, 2026	Apr 28, 2026	View filing
424B3	Apr 28, 2026	Apr 28, 2026	View filing
8-K	Apr 28, 2026	Apr 28, 2026	View filing
424B3	Apr 13, 2026	Apr 13, 2026	View filing
424B3	Apr 13, 2026	Apr 13, 2026	View filing
EFFECT	Apr 10, 2026	Apr 13, 2026	View filing
EFFECT	Apr 9, 2026	Apr 10, 2026	View filing
CORRESP	Apr 8, 2026	Apr 8, 2026	View filing
UPLOAD	Apr 8, 2026	Apr 8, 2026	View filing

SEC Filings

Recent Filings